[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 514
Citations 0
Comment & Response
August 21, 2013

Polypill for Cardiovascular Disease Prevention—Reply

Author Affiliations
  • 1UnitedHealth Chronic Disease Initiative, London, England
  • 2Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada
JAMA. 2013;310(7):749-750. doi:10.1001/jama.2013.16373

In Reply We do not at present recommend the use of combination therapy in all individuals older than 55 years. The value of using combination therapy for secondary prevention is well established; there was consensus among the participants at a global summit1 that large trials are needed to evaluate the role of the polypill in those at moderate to high risk of developing cardiovascular disease.

First Page Preview View Large
First page PDF preview
First page PDF preview